Skip to main content

UK Edition. Click here for US version.

CYCLOGEST 400MG

Active substance(s): PROGESTERONE

PDF options:  View Fullscreen   Download PDF

PDF Transcript

Package leaflet: Information for the user

400mg pessary
Cyclogest is the registered trademark of
L.D. Collins & Co. Ltd.
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
• If you get any side effects, talk to your doctor, pharmacist or nurse.
• Keep this leaflet. You may need to read it again.
This includes any possible side effects not listed in this leaflet. See
• If you have any further questions, ask your doctor, pharmacist or nurse.
section 4.
• This medicine has been prescribed for you. Do not pass it on to others.
It may harm them, even if their signs of illness are the same as yours.

What is in this leaflet
1 What Cyclogest is and what it is used for
2 What you need to know before you use Cyclogest
3 How to use Cyclogest
4 Possible side effects
5 How to store Cyclogest
6 Contents of the pack and other information
1 What Cyclogest is and what it is used for
Cyclogest contains progesterone which is a natural, female sex hormone,
produced in the body.
Cyclogest works by adjusting the hormonal balance within the body for the
treatment of:
• pre-menstrual syndrome which often affects women during the 7 to 10 days
before their monthly period. The symptoms of pre-menstrual syndrome include
feelings of tension, irritability, depression, headache, breast tenderness,
weight gain and bloatedness
• post-natal depression which some women get after their baby has been born.
• women who need extra progesterone while undergoing treatment in an
Assisted Reproductive Technology (ART) programme.

2 What you need to know before you use Cyclogest
Do not use Cyclogest if you:

• are allergic to progesterone or any of the other ingredients of this medicine
(listed in section 6),
• have unusual vaginal bleeding that has not been evaluated by the doctor,
• have known or suspected tumour that is hormone sensitive,
• have porphyria disorders (a group of inherited or acquired disorders of certain
enzymes),
• have or have had blood clots in the legs, lungs, eyes or elsewhere in the body,
• currently have or have had severe liver problems.
• have a miscarriage and your physician suspects some tissue is still in the
uterus or pregnancy outside of the womb.

Warnings and precautions

Talk to your doctor, pharmacist or nurse before using Cyclogest.
Take special care and tell your doctor straight away if you experience any of these
symptoms during treatment or even few days after the last dosage:
• pains in the calves or chest, a sudden shortness of breath or coughing blood
indicating possible clots in the legs, heart, or lungs
• severe headache or vomiting, dizziness, faintness, or changes in vision or
speech, weakness or numbness of an arm or leg indicating possible clots in the
brain or eye
• worsening of depression
Check with your doctor or pharmacist before using Cyclogest if you have or ever
have had:
• liver problems such as jaundice (yellowing of the skin and whites of the eyes).
• epilepsy
Continued top of next column

• migraine
• asthma
• cardiac or renal dysfunction
• diabetes

Children

There is no relevant use of Cyclogest in children.

Other medicines and Cyclogest

Tell your doctor or pharmacist if you are taking, have recently taken or might take
any other medicines. This is especially important in case you are taking
carbamazepine (e.g. to prevent fits, treat certain type of pain or mood disorders),
rifampicin (to treat infections) or phenytoin (e.g. to prevent fits or treat certain type
of pain) as they may decrease the effectiveness of progesterone.
Using other vaginal products at the same time as Cyclogest is used
vaginally is not recommended as it is not known if it affects the treatment.

Pregnancy and breast-feeding

Cyclogest can be used during the first trimester of pregnancy for women who
need extra progesterone while undergoing treatment in an Assisted Reproductive
Technology (ART) programme.
The risks of congenital (conditions present at birth) anomalies, including genital
abnormalities in male or female infants, from exposure to exogenous
progesterone during pregnancy have not been fully established.
For other use, if you are pregnant, think you may be pregnant or are planning
to have a baby, ask your doctor or pharmacist for advice before using this
medicine.
This medicine should not be used during breast feeding.

3 How to use Cyclogest
Always use this medicine exactly as your doctor has told you. Check with your
doctor or pharmacist if you are not sure.
For women undergoing Assisted Reproductive Technology (ART) programme:
The recommended dose is 400 mg twice a day by vaginal insertion. Start
using Cyclogest 400 mg on the day of egg retrieval. The administration of
Cyclogest should be continued for 38 days if pregnancy has been confirmed.
For the treatment of premenstrual syndrome and post-natal depression:
The recommended dose is 200 mg once a day or 400 mg twice a day by vaginal
or rectal insertion.
The pessary may be inserted into either the vagina or rectum (back passage)
depending upon the following certain other conditions.
You should insert Cyclogest into the:
• vagina if you have:
- colitis (inflammation of the colon causing frequent attacks of diarrhoea with
mucous or blood)
- problems controlling your bowel movements (faecal incontinence).
• rectum (back passage) if you have:
- a vaginal infection (discharge from your vagina)
- or often have cystitis (a burning pain on passing water)
- recently given birth
- to use a barrier method of birth control such as a diaphragm, cap or condom.
Such devices may not work properly in the presence of the vegetable fat from
the pessary.
Continued over page

For premenstrual tension start using Cyclogest on day 12 or 14 of your menstrual
cycle. This can be planned and marked onto your calendar; day 1 is the first day
of your monthly period, counting forward to day 12 or 14 as advised by your
doctor.
Do not swallow Cyclogest.
How to insert Cyclogest
Always wash your hands before and after inserting the pessary.
To insert into the:
• Vagina - place the pessary between the lips of the vagina and push the pessary
upwards and backwards. You may find it easier to do this if you are lying down
or squatting.
• Rectum (back passage) - gently push the pessary into the rectum for about
one inch. Your muscles will hold the pessary in place when it is in far enough.
Squeeze your buttocks together for a few seconds.
If you use more Cyclogest than you should
If you (or someone else) has accidentally swallowed any of the pessaries or you
use too many, contact your nearest hospital casualty department or your doctor
immediately for advice.

If you forget to use Cyclogest
If you forget to insert a pessary, do so as soon as you remember, unless it is
nearly time for the next dose. Never use two doses together. Remember to use
the remaining doses at the correct time.
If you stop using Cyclogest
Please consult your doctor or pharmacist for advice if you intend to stop or have
stopped using Cyclogest. Abrupt discontinuation of progesterone dosing may
cause increased anxiety, moodiness, and increased sensibility to seizures.
If you have any further questions on the use of this medicine, ask your doctor or
pharmacist.

4 Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody
gets them.
Stop using Cyclogest and contact your doctor at once if you have an allergic
reaction. Signs may include a skin rash, which may be itchy.
Common (may affect up to 1 in 10 people)
Drowsiness, stomach discomfort or pain, breast pain
Not known (frequency cannot be estimated from the available data)
Diarrhoea, soreness in your rectum (back passage), flatulence (wind), changes in
your menstrual cycle (you may find that your monthly period will start earlier than
usual or it may be delayed), leakage after the pessary has dissolved (this is quite
normal when using medicines that are inserted into the vagina or rectum)
Adverse reactions in patients undergoing ART treatment is presented below:
Common side effects (may affect up to 1 in 10 people):
• Abdominal distension (swelling in the abdomen), abdominal pain, constipation
• Sleepiness
• Tiredness
• Hot flush
• Breast pain
Uncommon side effects (may affect up to 1 in 100 people):
• Headache, dizziness, mood changes
• Change in taste, vomiting, flatulence (wind), diarrhoea, bloat (gastric dilatation),
rectal tumour
• Night sweats, skin rash or itching
• Joint pain
• Pelvic pain, ovarian enlargement, vaginal bleeding
• Frequent urination, involuntary excretion of urine
• Weight increase
• Bleeding
• Itching at the application site, feeling cold or body temperature change or
general discomfort

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This
includes any possible side effects not listed in this leaflet. You can also report
side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.
By reporting side effects you can help provide more information on the safety of
this medicine.

5 How to store Cyclogest
Keep this medicine out of the sight and reach of children.
Do not store above 30°C.
Do not use this medicine after the expiry date which is stated on the
label/carton/bottle. The expiry date refers to the last day of that month.
Do not throw away any medicines via wastewater or household waste.
Ask your pharmacist how to throw away medicines you no longer use.
These measures will help protect the environment.

6 Contents of the pack and other information
What Cyclogest contains

• The active substance (the ingredient that makes the medicine work) is
progesterone. Each pessary contains 400 mg of the active Ingredient.
• The other ingredients are vegetable fat.
What Cyclogest looks like ad contents of the pack
Cyclogest are off-white pessaries.
Pack sizes are 15.
Marketing Authorisation Holder
L.D. Collins & Co. Ltd.
1st Floor, Gallery Court, 28 Arcadia Avenue, London, N3 2FG, UK.
Manufacturer
Accord-UK Ltd., Barnstaple, EX32 8NS, UK.
This leaflet was last revised in August 2019.
Further Information:
Premenstrual Syndrome
Many women suffer from a condition called premenstrual syndrome or PMS. This
is commonly known as PMT (premenstrual tension) because of the anxiety and
bad temper often associated with it. However, there are many other symptoms
that occur with PMS including depression, bloating and breast tenderness. It is not
just your symptoms that decide whether you have PMS but the time at which they
are at their worst.
PMS is characterised by the symptoms that occur during the days leading up to
your period and are then completely relieved by menstruation. The cause of PMS
is not completely understood but it is believed to be related to the hormonal
changes that occur during the monthly cycle. Many women obtain relief from their
symptoms when their hormonal balance is altered with a medicine prescribed by
their doctor.
Further information about PMS can be obtained from:
National Association for Premenstrual Syndrome
41 Old Road
East Peckham
Kent
TN12 5AP
Post-Natal Depression
Many mothers experience short-term periods of mild depression following the
birth of their baby. This is a common condition, usually occurring three or four
days after delivery, affecting at least half of all new mothers who may feel tearful,
overwhelmed and irritable during this time. Support, reassurance and rest can
help these feelings to pass within a few days.
However, if the anxiety does not improve, the mother may be developing postnatal
depression. Up to 15 per cent of new mothers develop more severe symptoms
within 12 months of their child’s birth. Postnatal depression (PND) is
characterised by marked low mood for a more prolonged period of time.
Though it may take several weeks or months until a full recovery is reached, PND
is a treatable condition from which the mother will get better.
Speak to your midwife, health visitor or doctor if you have any further questions.

Continued top of next column

50981994

2064418

If you would like a leaflet with larger text,
please contact 020 7129 8660.

+ Expand Transcript

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.